Literature DB >> 7582529

Further evidence from functional studies for somatostatin receptor heterogeneity in guinea-pig isolated ileum, vas deferens and right atrium.

W Feniuk1, J Dimech, E M Jarvie, P P Humphrey.   

Abstract

1. Somatostatin (SRIF) causes a concentration-dependent inhibition of neurotransmission in guinea-pig ileum and vas deferens as well as negative inotropy in guinea-pig isolated right atrium. The SRIF receptors mediating these effects have now been further characterized by use of the peptides BIM-23027, BIM-23056 and L-362855, reported as selective for the recombinant SRIF receptor types, sst2, sst3 and sst5, respectively. 2. BIM-23027 was a highly potent agonist at causing an inhibition of neurotransmission in the guinea-pig ileum (EC50 value 1.9 nM), being about 3 times more potent than SRIF (EC50 value 6.8 nM). In contrast, in both guinea-pig vas deferens and right atrial preparations, BIM-23027 was a relatively weak agonist being at least 30-100 times weaker than SRIF. In guinea-pig atria, BIM-23027 (3 microM) antagonized the negative inotropic action of SRIF28 (apparent pKB = 5.9 +/- 0.1) but had no effect on the negative inotropic action of cyclohexyladenosine. 3. The inhibitory effect of BIM-23027 in the guinea-pig ileum was readily desensitized. Prior exposure to BIM-23027 (0.3 microM) markedly attenuated the inhibitory effect of SRIF but had no effect on the inhibitory action of clonidine suggesting that BIM-23027 and SRIF act via a common receptor mechanism. 4. L-362855 caused a concentration-dependent inhibition of neurotransmission in both the guinea-pig ileum and vas deferens as well as causing negative inotropy in the guinea-pig atrium but was at least 30-100 times weaker than SRIF. In guinea-pig isolated atria, L-362855 (3 microM) did not antagonize the negative inotropic action of SRIF28. 5. BIM-23056 in concentrations up to 1 microM was inactive as an agonist in guinea-pig isolated ileum, vas deferens and atrium and did not antagonize the inhibitory actions of SRIF in any of these preparations.6. The results from this study support our previous contention that the sst2 receptor type mediates inhibition of neurotransmission by SRIF in the guinea-pig ileum. The SRIF receptor type mediating inhibition of neurotransmission in the guinea-pig vas deferens appears different, but similar, to that mediating negative inotropy in the atrium. However the characteristics of these latter receptors appear different from that of the recombinant sst2, sst3 and sst5 receptors for SRIF described for rat and man.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582529      PMCID: PMC1909024          DOI: 10.1111/j.1476-5381.1995.tb15906.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Pharmacological properties of two cloned somatostatin receptors.

Authors:  S Rens-Domiano; S F Law; Y Yamada; S Seino; G I Bell; T Reisine
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

2.  Molecular cloning and functional expression of a brain-specific somatostatin receptor.

Authors:  J F Bruno; Y Xu; J Song; M Berelowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  Classification and nomenclature of somatostatin receptors.

Authors:  D Hoyer; G I Bell; M Berelowitz; J Epelbaum; W Feniuk; P P Humphrey; A M O'Carroll; Y C Patel; A Schonbrunn; J E Taylor
Journal:  Trends Pharmacol Sci       Date:  1995-03       Impact factor: 14.819

4.  Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion.

Authors:  L Mandarino; D Stenner; W Blanchard; S Nissen; J Gerich; N Ling; P Brazeau; P Bohlen; F Esch; R Guillemin
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

5.  Antagonist effects of seglitide (MK 678) at somatostatin receptors in guinea-pig isolated right atria.

Authors:  J Dimech; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

6.  Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.

Authors:  K Raynor; W A Murphy; D H Coy; J E Taylor; J P Moreau; K Yasuda; G I Bell; T Reisine
Journal:  Mol Pharmacol       Date:  1993-06       Impact factor: 4.436

7.  Cloning and expression of a novel mouse somatostatin receptor (SSTR2B).

Authors:  M Vanetti; M Kouba; X Wang; G Vogt; V Höllt
Journal:  FEBS Lett       Date:  1992-10-26       Impact factor: 4.124

8.  Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28.

Authors:  A M O'Carroll; S J Lolait; M König; L C Mahan
Journal:  Mol Pharmacol       Date:  1992-12       Impact factor: 4.436

9.  Potent inhibitory effects of a type four receptor-selective somatostatin analog on rat insulin release.

Authors:  W J Rossowski; D H Coy
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

10.  Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.

Authors:  T Reisine; H Kong; K Raynor; H Yano; J Takeda; K Yasuda; G I Bell
Journal:  Mol Pharmacol       Date:  1993-11       Impact factor: 4.436

View more
  4 in total

1.  Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine.

Authors:  M K Mundey; A Ali; R Mason; V G Wilson
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

2.  Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells.

Authors:  S W Castro; G Buell; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

3.  Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa.

Authors:  E S McKeen; W Feniuk; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

4.  Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones.

Authors:  I P Chessell; M D Black; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.